Treatment patterns and costs among patients with OAB treated with combination oral therapy, sacral nerve stimulation, percutaneous tibial nerve stimulation, or onabotulinumtoxinA in the United States

INTRODUCTION: Treatment patterns and costs were characterized among patients with overactive bladder (OAB) receiving later‐line target therapies (combination mirabegron/antimuscarinic, sacral nerve stimulation [SNS], percutaneous tibial nerve stimulation [PTNS], or onabotulinumtoxinA). METHODS: In a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kraus, Stephen R., Shiozawa, Aki, Szabo, Shelagh M., Qian, Christina, Rogula, Basia, Hairston, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Clinical Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693053/
https://www.ncbi.nlm.nih.gov/pubmed/32827230
http://dx.doi.org/10.1002/nau.24474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693053/
https://www.ncbi.nlm.nih.gov/pubmed/32827230
http://dx.doi.org/10.1002/nau.24474

Ejemplares similares